Please ensure Javascript is enabled for purposes of website accessibility

Celgene?s Cancer Drug Trial Turns Heads

Summit

Celgene?s new cancer drug Revlimid is reporting the kind of clinical results that makeSummit

Celgene?s new cancer drug Revlimid is reporting the kind of clinical results that make

NJBIZ Business Events

2022 NJBIZ Energy Panel Discussion

Tuesday, October 18, 2022
2022 NJBIZ Energy Panel Discussion

NJBIZ Best 50 Women in Business 2022

Wednesday, October 26, 2022
NJBIZ Best 50 Women in Business 2022

NJBIZ Business of the Year 2022

Tuesday, December 13, 2022
NJBIZ Business of the Year 2022